The Commission should purchase the antigens, vaccines and diagnostic reagents to be supplied to the Union antigen, vaccine and diagnostic reagent banks and should cover the expenses for the storage of the antigens, vaccines and diagnostic reagents therein. In order to establish and maintain those banks, the Commission should conclude appropriate contracts with selected manufacturers for the purchase, supply, storage and replacement of antigens, vaccines or diagnostic reagents. For that purpose, a procurement procedure should be carried out in accordance with the rules laid down in Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council [Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council of 18 July 2018 on the financial rules applicable to the general budget of the Union, amending Regulations (EU) No 1296/2013, (EU) No 1301/2013, (EU) No 1303/2013, (EU) No 1304/2013, (EU) No 1309/2013, (EU) No 1316/2013, (EU) No 223/2014, (EU) No 283/2014, and Decision No 541/2014/EU and repealing Regulation (EU, Euratom) No 966/2012 (OJ L 193, 30.7.2018, p. 1).].
Recital 3, Regulation (EU) 2022/139
In forcesince 16 Nov 2021
Regulation (EU) No 1301/2013 of the European Parliament and of the Council of 17 Decembe…Law
Regulation (EU) No 1303/2013 of the European Parliament and of the Council of 17 Decembe…Law
Regulation (EU) No 1304/2013 of the European Parliament and of the Council of 17 Decembe…Law
Regulation (EU) No 223/2014 of the European Parliament and of the Council of 11 March 20…Law
- celex=32013R1296
- celex=32013R1309
- celex=32013R1316
- celex=32014D0541
- celex=32014R0283